Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 838-845

  Sadoff, J D ^a   Scholz, P M ^a   Tse, J ^a   Weiss, H R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

aortic valve stenosis; coronary blood flow; dog; myocardial O2 consumption; myocardial work

Indexed keywords

CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; GUANYLATE CYCLASE; HEART ENZYME; LINSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA VALVE STENOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; ENZYME ACTIVITY; HEART LEFT VENTRICLE HYPERTROPHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SECOND MESSENGER;

EID: 0029961427     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118856     Document Type: Article

References (37)

1. Lohmann, S.M., R. Fischmeister, and U. Walter. 1991. Signal transduction by cGMP in heart. Basic Res. Cardiol. 86:503-514.
2. Roitstein, A., J. Kedem, B. Cheinberg, H.R. Weiss, J. Tse, and P.M. Scholz. 1994. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy. J. Surg. Res. 57:584-590.
3. Sperelakis, N., N. Tohse, Y. Ohya, and H. Masuda. 1994. Cyclic GMP regulation of calcium slow channels in cardiac muscle and vascular smooth muscle cells. Adv. Pharmacol. 26:217-252.
4. 2+ in intact cardiac myocytes. Circ. Res. 74:970-978.
5. Paulus, W.J., P.J. Vantrimpont, and A.M. Shah. 1994. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment of bicoronary sodium nitroprusside infusion. Circulation. 89:2070-2078.
6. Watanabe, A.M., and H.R. Besch, Jr. 1975. Interaction between cyclic adenosine monophosphate and cyclic guanosine monophosphate in guinea pig ventricular myocardium. Circ. Res. 37:309-317.
7. Guo, X., J. Kedem, A. Roitstein, J. Tse, P.M. Scholz, and H.R. Weiss. 1994. Effect of intracoronary methylene blue on regional myocardial mechanics and cyclic GMP in experimental left ventricular hypertrophy (LVH). FASEB J. 8:310a. (Abstr.)
8. Weiss, H.R., E. Rodriguez, J. Tse, and P.M. Scholz. 1994. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin. Exp. Pharm. Physiol. 21:607-614.
9. 4-induced cardiac hypertrophy. Am. J. Physiol. 268:H686-H691.
10. Murad, F., V. Forstermann, M. Nakane, H. Schmidt, J. Pollock, H. Sheng, T. Matsumoto, T. Warner, J. Mitchell, R. Tracey, and W. Buechler. 1992. The nitric oxide-cGMP signal transduction pathway in vascular smooth muscle preparations and other tissues. Jpn. J. Pharmacol. 58(Suppl. 2): 150-157.
11. Paulus, W.J. 1994. Endothelial control of vascular and myocardial function in heart failure. Cardiovasc. Drugs Ther. 8:437-446.
12. Schini, V.B., and P.M. Vanhoutte. 1993. Role of the L-arginine-nitric oxide pathway in vascular smooth muscle. Eur. Heart J. 14(Suppl. 1): 16-21.
13. Gurevicius, J., M.R. Salem, A.A. Metwally, J.M. Silver, and G.J. Crystal. 1995. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis. Am. J. Physiol. 268:H39-H47.
14. Kirkeboen, K.A., P.A. Naess, J. Offstad, and A. Ilebekk. 1994. Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts. Am. J. Physiol. 266:H1516-H1527.
15. Brady, A.B., J.B. Warren, P. Poole-Wilson, T. Williams, and S.E. Harding. 1993. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265:H176-H182.
16. Kelm, M., and J. Schrader. 1990. Control of coronary vascular tone by nitric oxide. Circ. Res. 66:1561-1575.
17. Nichols, J.R., and N.C. Gonzalez. 1982. Increase in myocardial cell cGMP concentration in pressure-induced myocardial hypertrophy. J. Mol. Cell. Cardiol. 14:181-183.
18. Jakob, G., J. Mair, M. Pichler, and B. Puschendorf. 1995. Ergometric testing and sensitivity of cyclic guanosine 3′,5′-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction. B. Heart J. 73:145-150.
19. Michel, J.B., J.J. Mercadier, F.X. Galen, R. Urbain, J.C. Dussaule, M. Philippe, and P. Corvol. 1990. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats. Cardiovasc. Res. 24: 946-952.
20. Smith, T.P. Jr., and J.M. Canty, Jr. 1993. Modulation of coronary autoregulatory responses by nitric oxide: evidence for flow-dependent resistance adjustments in conscious dogs. Circ. Res. 73:232-240.
21. Wahler, G.M., and S.J. Dollinger. 1995. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol. 268:C45-C54.
22. Scholz, P.M., M.E. Upsher, E. Eliades, J. Kedem, and H.R. Weiss. 1990. Alterations in the regional β-adrenergic system in experimental left ventricular hypertrophy. Cardiovasc. Res. 24:65-71.
23. Scholz, P.M., G.J. Grover, J.W. Mackenzie, and H.R. Weiss. 1990. Regional oxygen supply and consumption balance in experimental left ventricular hypertrophy. Basic Res. Cardiol. 85:575-584.
24. 2 consumption in experimental left ventricular hypertrophy: effect of negative inotropes. Life Sci. 53:1847-1858.
25. Calderone, A., M. Bouvier, K. Li, C. Juneau, J. de Champlain, and J.-L. Rouleau. 1991. Dysfunction of the β- and α-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ. Res. 69:332-343.
26. Kimura, H., C.K. Mittal, and F. Murad. 1975. Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J. Biol. Chem. 250: 8016-8022.
27. Tse, J., R. Wrenn, and J.F. Kuo. 1980. Thyroxine-induced changes in characteristics and activities of beta-adrenergic receptors and adenosine 3′, 5′-monophosphate and guanosine 3′:5′-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism. Endocrinology. 107:6-16.
28. Wilkins, M.R., and P. Needleman. 1992. Effect of pharmacological manipulation of endogenous atriopeptin activity on renal function. Am. J. Physiol. 262:F161-F167.
29. Shah, A.M., and M.J. Lewis. 1992. Endothelial modulation of myocardial contraction: mechanisms and potential relevance in cardiac disease. Basic Res. Cardiol. 87(Suppl. 2):59-70.
30. Marcin, N., U.S. Ryan, and J.D. Catravas. 1992. Methylene blue inhibits nitrovasodilator and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J. Pharm. Exp. Ther. 263:170-179.
31. Dowell, R.T., J.L. Haithcoat, H.M. Thirkill, and W.K. Palmer. 1984. Heart cyclic nucleotide responses to sustained aortic constriction in neonatal and adult rats. Am. J. Physiol. 246:H197-H206.
32. Legato, M.J. 1979. Cellular mechanisms of normal growth in the mammalian heart. I. Qualitative and quantitative features of ventricular architecture in the dog from birth to five months of age. Circ. Res. 44:250-262.
33. Thompson, E.W. 1994. Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement. Proc. Soc. Exp. Biol. Med. 205:294-305.
34. 2 consumption to a greater extent under conditions of increased metabolism. FASEB J. 10:314a. (Abstr.)
35. Grocott-Mason, R., P. Anning, H. Evans, M.J. Lewis, and A.M. Shah. 1994. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am. J. Physiol. 267:H1804-H1813.
36. Brown, L.A., D.J. Nunez, and M.R. Wilkins. 1993. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J. Clin. Invest. 92:2702-2712.
37. Vatner, D.E., D.L. Lee, K.R. Schwarz, J.P. Longabaugh, A.M. Fujii, S.F. Vatner, and C.J. Homey. 1988. Impaired muscarinic receptor function in dogs with heart failure. J. Clin. Invest. 81:1836-1842.